Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve

Figure 1 Patient treated with silver sulphadiazine cream for more than 24 h in the pre-Nexobrid^® treatment. A: Patient where silver sulphadiazine cream was applied in the pre-Nexobrid^® treatment for more than 24 h; B: After 4 h of exposure to Nexobrid^®, the incomplete removal of eschar is shown.